Additionally, IFI16 has been shown to suppress the activation of other inflammasomes, such as AIM2 and NLRP3, thereby modulating inflammatory responses in a way that can either promote or inhibit tumor progression depending on the context (11). The gene discussed is AIM2; the disease is neoplasm.